Cal-Maine Foods is an unusual animal in the food sector this week — short interest running above 11% of the float while the stock has rallied 5% over the past week and 12% over the past month, creating a tension between bearish positioning and a recovering price.
The short side has not capitulated. Short interest finished Tuesday at 11.5% of the free float, a level that has climbed roughly 13% over the past month even as the stock moved higher. The week was choppy — shorts rose modestly on a net basis despite an intraday dip on Tuesday — suggesting sellers are holding their ground rather than covering into the rally. That said, the borrow market does not look stressed. Availability is generous at 236%, meaning there are more than two shares available to borrow for every share already shorted, well within the normal range and up sharply on the week. Cost to borrow is a negligible 0.48%, barely changed in real terms, so there is no squeeze pressure coming from the lending side. Options positioning tells a slightly more defensive story: the put/call ratio is running at 1.09, a standard deviation above its 20-day average of 0.98, suggesting the options market is carrying more downside hedging than usual — though the reading is a long way from the 52-week high of 2.04 hit earlier in the year.
The Street is broadly neutral but in a slow retreat on price targets. Stephens & Co. trimmed their target to $85 from $90 earlier this month while holding an Equal-Weight rating — a signal of caution rather than conviction in either direction. The consensus mean target of $84.25 is now marginally below the current price of $87.25, which is an unusual positioning for a stock in the middle of a monthly rally. BMO Capital and Goldman Sachs have similarly maintained cautious ratings while nudging targets lower over the past six months. The factor scores back up the Street's hesitancy: EPS momentum ranks in the bottom quartile on both 30-day and 90-day windows, and the 12-month forward EPS growth rank is near the floor at 14. The one bright spot is the EPS surprise score at 82, meaning Cal-Maine has consistently beaten consensus estimates even as the trend in estimates moves down. Valuation is undemanding at roughly 12x trailing earnings and 1.25x book, consistent with a commodity-driven business in a price-normalisation phase.
The bull and bear cases are essentially a debate about egg-price trajectory. The bull argument rests on the 72% revenue surge that Cal-Maine delivered when average egg prices hit $3.31 per dozen, plus management's commitment to growing prepared-foods capacity by 30% or more over the next 18-24 months. The bear case is that those peak prices are behind the company: EPS estimates have already been cut from $8.08 to $7.57, the conventional flock is down 13.6% year-on-year, and net sales in the most recent comparative period fell 19%. The ORTEX short score of 67.9 — moderately elevated but down slightly from a recent peak of 70.4 last Thursday — reflects a market that sees genuine risk here without making an extreme bet.
Institutionally, BlackRock added 408,000 shares in the most recent quarter to reach 14.7% of the company, a notable addition. American Century also added meaningfully, as did Dimensional and River Road. The insider file is stale — the last trades on record were token disposals by the CFO and CEO in January at $72.44, well below the current price — so that data adds little to the current read.
Next up is the Q1 FY2027 earnings call scheduled for September 29. Between now and then, the key variable is whether weekly egg price data softens further or stabilises — that will determine whether the 11% short interest builds toward a genuine squeeze setup or shorts find their thesis confirmed.
See the live data behind this article on ORTEX.
Open CALM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
